[symposium-forum cat=”1″]
Feedback
Recent Posts
- New inhaled therapy for pulmonary hypertension in development
- Transplants are still too difficult to schedule for PH patients
- FDA grants fast track status to CS1, Cereno’s therapy candidate for PAH
- At diagnosis, Black PAH patients have more severe disease: Study
- Using 4-drug combination therapy adds up to healing in PAH